9.38 USD
↗ 0.23 (2.51%)AT CLOSE (11:59 AM EDT)
LENZ Therapeutics, Inc. Common Stock
LENZNASDAQ • USD
9.45
↗ 0.07 (0.75%)
POST MARKET (AS OF 07:39 PM EDT)
Post Market
AS OF 07:39 PM EDT
9.45
↗ 0.07 (0.75%)
Market: CLOSED
Open?$9.17
High?$9.48
Low?$8.95
Prev. Close?$9.15
Volume?656.1K
Avg. Volume?1.1M
VWAP?$9.28
Rel. Volume?0.62x
Bid / Ask
Bid?$9.15 × 400
Ask?$9.75 × 8.0K
Spread?$0.60
Midpoint?$9.45
Valuation & Ratios
Market Cap?294.1M
Shares Out?31.4M
Float?18.2M
Float %?58.2%
P/E Ratio?N/A
P/B Ratio?1.03
EPS?-$2.62
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?14.23Strong
Quick Ratio?14.09Strong
Cash Ratio?1.19Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score67/100
P/E?N/A▾
P/B?1.03CHEAP▾
P/S?15.41HIGH▾
P/FCF?N/A▾
EV/EBITDA?-3.0CHEAP▾
EV/Sales?14.09HIGH▾
Returns & Efficiency
ROE?-28.9%WEAK▾
ROA?-26.8%WEAK▾
Cash Flow & Enterprise
FCF?$-69997000
Enterprise Value?$268.9M
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.
Employees
152
Market Cap
294.1M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2024-03-22
Address
201 LOMAS SANTA FE DRIVE, SUITE 300
SOLANA BEACH, CA 92075
Phone: 858-925-7000
SOLANA BEACH, CA 92075
Phone: 858-925-7000